|
1. Biologie
|
|
|
|
|
3.1 Prévention - Tabac
|
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
Genomics – on an industrial scale [Genomics England]
|
|
|
|
|
|
Genomics
is made up of many moving parts − from the understanding and consent of
the public, to truly pioneering research, to building an effective NHS
infrastructure. But make no mistake, the Discovery Forum and the
industry partnerships it builds are every bit as important to the
success of genomic medicine.
|
|
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
Tito Fojo: Cancer drugs not delivering on their potential [Cancer World]
|
|
|
|
|
|
Tito
Fojo told WOF, at its meeting in Lugano in October, “Every therapy that
we begin on a patient has a chance to benefit them, but it also has a
chance to harm them. If on top of that you add the harm that comes from
the toxicity of drugs, a lot of therapies are actually more likely to
harm you than to benefit you.”
|
|
|
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
|
5.8.2 ASH - Pharma
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
|
|
6.3 Associations/Fondations
|
|
|